Last update 07 Jun 2025

Fimasartan Potassium Trihydrate/Indapamide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fimasartan/Indapamide, BR 1015, BR-1015
+ [1]
Target
AT1R x NCC
Action
antagonists, inhibitors
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors)
Therapeutic Areas
Cardiovascular Diseases
Active Indication
Essential Hypertension
Inactive Indication-
Originator Organization
Boryung Corp.Boryung Corp.
Active Organization
Boryung Corp.Boryung Corp.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC16H16ClN3O3S
InChIKeyNDDAHWYSQHTHNT-UHFFFAOYSA-N
CAS Registry26807-65-8
View All Structures (2)

Related

7
Clinical Trials associated with Fimasartan Potassium Trihydrate/Indapamide
NCT06744439
/ CompletedPhase 1
An Open-label, Randomized, Fed, Single-dose, 2-sequence, 4-period, Crossover Phase I Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 in Healthy Volunteers
NCT06744062
/ CompletedPhase 1
An Open-label, Randomized, Fed, Single-dose, 2-sequence, 4-period, Crossover Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers
NCT06744426
/ CompletedPhase 1
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 4-period, Crossover Phase I Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 in Healthy Volunteers
100 Clinical Results associated with Fimasartan Potassium Trihydrate/Indapamide
Login to view more data
100 Translational Medicine associated with Fimasartan Potassium Trihydrate/Indapamide
Login to view more data
100 Patents (Medical) associated with Fimasartan Potassium Trihydrate/Indapamide
Login to view more data
100 Deals associated with Fimasartan Potassium Trihydrate/Indapamide
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Essential HypertensionPhase 3
United States
Boryung Corp.Boryung Corp.
09 Nov 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free